Recent Press Releases

Enigma Diagnostics Inks Pact, Banks $50 Million Investment

Enigma Diagnostics Inks Pact, Banks $50 Million Investment Enigma Diagnostics Signs Joint Venture Agreement with Beijing Leadman Biochemistry and Announces US$50 Million Investment Agreement will...

AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode

SAN DIEGO, Oct. 22, 2014 /PRNewswire/ -- AVACEN Medical announced today that its AVACEN 100 Class II medical device received 510 (k) OTC clearance by the U.S. Food and Drug Administration. This...

XPRIZE Announces Finalists for $2.25 Million Nokia Sensing XCHALLENGE

LOS ANGELES, Oct 21, 2014 (BUSINESS WIRE) -- XPRIZE, the global leader in incentivized prize competition, today announced the 11 finalist teams selected for the $2.25M Nokia Sensing XCHALLENGE, a...

Materialise Acquires Orthoview, The Market Leader In Orthopedic Digital Pre-Operative Planning Software

LEUVEN, Belgium, Oct. 21, 2014 (GLOBE NEWSWIRE) -- Materialise NV (Nasdaq:MTLS) today announced the acquisition of UK-based OrthoView Holdings Limited, the world's leading provider of 2D digital...

AirStrip to Provide Mobile Monitoring and Early Patient Warning Technology Using IBM's Real-Time Analytics

ARMONK, N.Y. & SAN ANTONIO, Texas--(BUSINESS WIRE)-- AirStrip®and IBM (NSYE:IBM) today announced that AirStrip will work to develop a mobile monitoring solution to help clinicians predict...

SORIN GROUP PARTNERS WITH RESPICARDIA, INC., A DEVELOPER OF INNOVATIVE IMPLANTABLE THERAPIES DESIGNED TO IMPROVE RESPIRATORY AND CARDIOVASCULAR HEALTH

Investment will fund on-going clinical testing of the remedē® System for patients with central sleep apnea, a significant co-morbidity in heart failure. Commercial launch of the product by Sorin...

AliveCor Honored as one of FierceMedicalDevices' Fierce 15 Most Promising Private

SAN FRANCISCO, Calif. October 21, 2014 – AliveCor, Inc. announced today that the company has been named one of the Fierce 15 most promising privately held medical device and diagnostic...

First Patient Successfully Implanted in Safety/Efficacy Study of Beta-O2's ßAir Bio-Artificial Pancreas for Type 1 Diabetes

Uppsala University Hospital in Sweden will enroll 8 patients in the study, partially supported by a recent grant by the JDRF ROSH HAAYIN, Israel, October 21, 2014 /PRNewswire/ -- Beta-O2 announced...

Optos Plc (OPTS.L) Unveils California, Its Next Generation Ultra-Wide Imaging Device For The Ophthalmology Market

LONDON, UK, 20 October 2014 – Optos plc (LSE: OPTS), the leading medical retinal imaging company, is pleased to announce that California, the second device from its next generation...

New test scans all genes to ID single mutation causing rare disorders

Audrey Lapidus adored her baby's sunny smile and irresistible dimples, but grew worried when Calvin did not roll over or crawl by 10 months and suffered chronic digestive problems. Four...

Medrobotics Snags $20 Million

RAYNHAM, Mass.--(BUSINESS WIRE)--Medrobotics Corp., a surgical products company with core competencies in medical robotics, today announced that it had closed a $20 Million Preferred Stock financing....

Philips' Third Quarter Results 2014

Comparable sales growth flat, with sales in growth geographies up 2% EBITA, excluding restructuring and acquisition-related charges and other items, amounted to EUR 536 million, or 9.7% of sales,...

Tear duct implant effective at reducing pain, inflammation in cataract surgery patients

CHICAGO, Oct. 19, 2014 /PRNewswire-USNewswire/ -- The first tear duct implant developed to treat inflammation and pain following cataract surgery has been shown to be a reliable alternative to...

Finalists for Children's National Health System pediatric medical device competition announced

WASHINGTON, Oct. 16, 2014 /PRNewswire-USNewswire/ -- Eight finalists, all representing outstanding innovation in pediatric medical devices, have been selected to present their proposals for a chance...

FDA Approves Dexcom SHARE™, the First Remote Mobile Communications Device Used for Continuous Glucose Monitoring (CGM)

FDA Approves Dexcom SHARE™, the First Remote Mobile Communications Device Used for Continuous Glucose Monitoring (CGM) SAN DIEGO, Oct 20, 2014 (BUSINESS WIRE) -- Dexcom, Inc. DXCM, +1.24% a...

ZetrOZ nabs $5 mln loan from Horizon

TRUMBULL, CT and FARMINGTON, CT–(Marketwired – Oct 17, 2014) – ZetrOZ, Inc. today announced that it has received a $5 million venture loan facility from Horizon Technology Finance...

Veran Medical Completes $12 Million in New Financing

ST. LOUIS, Mo., Oct. 20, 2014 /PRNewswire/ -- Veran Medical Technologies, a market leader in thoracic navigation for early detection of lung cancer, announced today the completion of a $12M financing...

Reprogenetics, LLC Announces Strategic Collaboration For Next-Generation In-Vitro Fertilization Sequencing Systems

LIVINGSTON, NJ--(Marketwired - October 16, 2014) - Reprogenetics, the largest U.S. genetics laboratory specializing in Preimplantation Genetic Screening (PGS) and Preimplantation Genetic Diagnosis...

MedAvail Completes $30 Million Series C Financing

Company Now Poised and Capitalized For Commercial Release of the MedAvail MedCenter® Tele-Pharmacy Systems TORONTO, Oct. 16, 2014 /CNW/ - MedAvail Technologies Inc., announced today the...

CD&R hires ex-GE Healthcare CEO as operating advisor for funds

NEW YORK, Oct. 16, 2014 /PRNewswire/ — Clayton, Dubilier & Rice ("CD&R") has appointed John Dineen as an Operating Advisor to CD&R's funds, effective early next year, to focus...